MJBizDaily has highlighted a simple proposition: genetics are the cannabis industry’s most valuable asset. For breeders, seedbanks, producers and distributors that claim to sell consistency, potency or therapeutic value, that statement should change how contracts, quality assurance and corporate strategy are organised.

Wholesale buyers looking for feminized cannabis seeds need more than a familiar strain name. Prioritise genetic provenance, phenotype stability, germination performance, batch traceability, IP and licensing, and consistent B2B terms. This article provides practical checks and commercial implications to help seedbanks, distributors and growshops evaluate suppliers and align selections to catalogue strategy.

This article explains why provenance is a commercial procurement issue for seedbanks, breeders and distributors. It gives practical checks to assess genetic origin, traceability and supplier fit so you can reduce catalogue risk, protect IP and plan reliable product lines.